At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
Meanwhile, sickle cell gene therapies Casgevy and Lyfgenia cost $2.2 million and $3.1 million, respectively. More than half of people in the U.S. with sickle cell disease are enrolled in Medicaid ...
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...
Sebastien Beauzile became the first person in NY to be made symptom-free after undergoing a new type of gene therapy.
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
(CNN) — The US Food and Drug Administration on Friday approved two gene-based treatments for sickle cell disease, including the first therapy that uses the gene-editing technique CRISPR ...
1monon MSN
Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health ...
A gene known as HbS was the center of a medical and evolutionary detective story that began in the middle 1940s in Africa. Doctors noticed that patients who had sickle cell anemia, a serious ...
Associated Press Friday, Dec. 8, 2023 12:50 p.m. | Friday, Dec. 8, 2023 12:50 p.m. Regulators on Friday approved two new gene therapies for sickle cell disease that doctors hope can cure the ...
The influential Institute for Clinical and Economic Review (ICER) in the US has issued draft guidance suggesting that new gene therapies for sickle cell disease (SCD) from Vertex Pharma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results